Results 11 to 20 of about 2,304,798 (264)
American Journal of Transplantation, 2021 COVID‐19 is associated with increased morbidity and mortality in transplant recipients. There are no efficacy data available regarding these patients with any of the available SARS‐CoV‐2 vaccines.
A. Grupper +14 more
semanticscholar +1 more source
Induction immunosuppression and outcome in kidney transplant recipients with early COVID-19 after transplantation [PDF]
, 2022 COVID-19 in kidney transplants has a high risk of complications and mortality, especially in older recipients diagnosed during the early period after transplantation. Management of immunosuppression has been challenging during the pandemic.
Llinàs-Mallol, Laura +24 more
core +3 more sources
Journal of the American Society of Nephrology, 2021 Visual Abstract Significance Statement Data are lacking on the humoral response to COVID-19 vaccination in kidney transplant recipients and patients on hemodialysis. This study of humoral response to an mRNA vaccine in 78 patients undergoing hemodialysis,
C. Danthu +14 more
semanticscholar +1 more source
Kidney International, 2021 2021 marks the 30th anniversary of the original development of the Banff Classification of Kidney Allograft Pathology, when in August 1991 a group of pathologists and transplant clinicians led by Kim Solez and Lorraine Racusen met in Banff, Alberta ...
A. Loupy, M. Mengel, M. Haas
semanticscholar +1 more source
Allorecognition and the spectrum of kidney transplant rejection.
Kidney International, 2021 Detection of mismatched human leukocyte antigens (HLA) by adaptive immune cells is considered as the main cause of transplant rejection, leading to either T-cell mediated rejection (TCMR) or antibody-mediated rejection (ABMR).
J. Callemeyn +5 more
semanticscholar +1 more source
Transplantation, 2021 Background. In kidney patients COVID-19 is associated with severely increased morbidity and mortality. A comprehensive comparison of the immunogenicity, tolerability, and safety of COVID-19 vaccination in different cohorts of kidney patients and a ...
J. Sanders +25 more
semanticscholar +1 more source
Transplant International, 2022 This guideline, from a European Society of Organ Transplantation (ESOT) working group, concerns the management of kidney transplant patients with HLA antibodies.
N. Mamode +7 more
semanticscholar +1 more source
Social Determinants of Health and Race Disparities in Kidney Transplant.
American Society of Nephrology. Clinical Journal, 2021 BACKGROUND AND OBJECTIVES Black patients have a higher incidence of kidney failure but lower rate of deceased- and living-donor kidney transplantation compared with White patients, even after taking differences in comorbidities into account.
Hannah M. Wesselman +12 more
semanticscholar +1 more source
COVID-19 vaccination in kidney transplant recipients
Nature Reviews Nephrology, 2021 Kidney transplant recipients receive therapeutic immunosuppression that impairs their immune responses to the COVID-19 mRNA vaccine. For this reason, this vulnerable patient population is insufficiently protected by the standard two-dose COVID-19 ...
S. Caillard, O. Thaunat
semanticscholar +1 more source
JAMA Internal Medicine, 2021 Key Points Question Does a heterologous SARS-CoV-2 vaccination strategy with the vector vaccine Ad26COVS1 result in a higher rate of antibody response compared with a homologous third dose of mRNA vaccine (mRNA-1273 or BNT162b2) in kidney transplant ...
R. Reindl-Schwaighofer +28 more
semanticscholar +1 more source